Highlights
A collection of news and information related to Plavix (drug) published by this site and its partners.
Displaying items 1-12 of 29
» View wsbt.com items only
1
2
3
Next >
-
CONSUMER REPORTS: Big name drug savings
If you take Lipitor, Actos, or Lexapro, new generics of these and other big-name drugs could be a real money saver. But are you saving as much as you should? Consumer Reports has discovered just because you're buying a generic drug doesn't mean you're...
Tags: Consumers, Actos (drug), Prescription Drugs, Asthma, CVS Corp.
-
Shop around for deals on prescription drugs
If your insurance has ever stopped covering a prescription drug or you don’t have coverage at all, you know how quickly costs can mount. Americans spent, on average, $758 out of pocket for medication in 2012, according to a recent Consumer Reports...Tags: Consumers, Actos (drug), Prescription Drugs, Asthma, Chemical Industry
-
RPT-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices
Reuters(Repeats to widen readership) By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc...Tags: Government, Barack Obama, Deloitte Touche Tohmatsu Ltd., Social Sciences, Politics
-
U.S. spending on medicines fell for first time in 2012
Reuters(Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years, according to a report released on Thursday. Overall U.S....Tags: Bristol Myers Squibb Company, Prescription Drugs, Pfizer Inc., Patient Protection and Affordable Care Act, Health Insurance Cost
-
XxANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices
ReutersBy Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and AstraZeneca have grown...Tags: Government, Barack Obama, Deloitte Touche Tohmatsu Ltd., Social Sciences, Politics
-
REFILE-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices
Reuters(Removes "XX" from headline) By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and...Tags: Government, Barack Obama, Deloitte Touche Tohmatsu Ltd., Social Sciences, Politics
-
Spending on drugs falls for first time in 55 years
ReutersThe amount of money Americans spend on prescription drugs fell for the first time in 55 years, according to a report from the IMS Institute of Healthcare Informatic. The expiration of patents on widley used drugs such drugs such as Lipitor and Plaviix...Tags: Bristol Myers Squibb Company, Lipitor (drug), Patents, Copyrights and Trademarks, AstraZeneca Plc, Pfizer Inc.
-
Drug spending falls for first time in 6 decades
An explosion of cheap generic substitutes for widely used prescription drugs last year helped drive the first decline in pharmaceutical spending in the U.S. in nearly six decades. Drug makers often lament what they call the patent cliff, which is when...
Tags: Consumers, Pharmaceuticals, Lipitor (drug), Patents, Copyrights and Trademarks, Health Insurance
-
More people buying prescription drugs overseas online
Reporter and PhotographerThe federal government doesn't want you to do it but more and more of you are. The high cost of prescription drugs has many Americans turning to other countries to make their purchases. The Food and Drug Administration says that's dangerous. More...Tags: Food and Drug Administration, Viagra (drug), Pharmaceuticals, Pfizer Inc., Prescription Drugs
-
Patients settle stent claims against Midei, St. Joseph
Nearly 250 of the patients who accused cardiologist Dr. Mark Midei of performing unnecessary stent procedures at St. Joseph Medical Center settled their lawsuits against him Thursday, a major step forward in one of the largest medical malpractice cases in...
Tags: Lawyers, General Practitioners, University of Baltimore, St. Joseph Medical Center, Towson
-
Strategies for cutting the cost of prescription drugs
When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it. The 59-year-...
Tags: Consumers, Oncology, Herceptin (drug), Prescription Drugs, Cedars-Sinai Medical Center
-
Sinai to research new drug to prevent blood clots, heart attacks in stent patients
A Sinai Hospital cardiologist is launching a clinical trial of a type of coronary artery disease drug not yet tested in humans, building on a history at the Baltimore hospital of research to develop more effective treatments to prevent blood clotting....
Tags: Health and Safety at School, Heart Attack, Science and Technology, Medical Research, Chemical Industry
Apr 15, 2013
|Story| WSBT-TV
May 12, 2013
|Story| Herald Mail
May 10, 2013
|Story| Reuters
May 8, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 9, 2013
|Story| Los Angeles Times
May 7, 2013
|Story| KSPR-TV
May 2, 2013
|Story| Baltimore Sun
Apr 19, 2013
|Story| Los Angeles Times
Apr 26, 2013
|Story| Baltimore Sun
Original site for Plavix (drug) topic gallery.